Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial

BACKGROUND: The newly discovered coronavirus has turned into coronavirus disease 2019 (COVID-19) pandemic and it rages at an unprecedented rate. Considering the findings of previous studies on the use of Intravenous Immunoglobulin (IVIg) for treating severe H(1)N(1) infection and the satisfying resu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int Immunopharmacol
Hlavní autoři: Tabarsi, Payam, Barati, Saghar, Jamaati, Hamidreza, Haseli, Sara, Marjani, Majid, Moniri, Afshin, Abtahian, Zahra, Dastan, Alireza, Yousefian, Sahar, Eskandari, Raha, Saffaei, Ali, Monjazebi, Fatemeh, Vahedi, Abdolbaset, Dastan, Farzaneh
Médium: Artigo
Jazyk:Inglês
Vydáno: Published by Elsevier B.V. 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7665876/
https://ncbi.nlm.nih.gov/pubmed/33214093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2020.107205
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky